Hemcheck Sweden AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HEMC.ST research report →
Companywww.hemcheck.com
Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States.
- CEO
- Joen Averstad
- IPO
- 2017
- Employees
- 1
- HQ
- Karlstad, SE
Price Chart
Valuation
- Market Cap
- $8.63M
- P/E
- -0.24
- P/S
- 6.54
- P/B
- 0.14
- EV/EBITDA
- -0.70
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 276.02%
- Op Margin
- -1131.28%
- Net Margin
- -1126.68%
- ROE
- -50.87%
- ROIC
- -59.78%
Growth & Income
- Revenue
- $1.32M · 17.78%
- Net Income
- $-14,869,784 · -6.55%
- EPS
- $-0.95 · -30.14%
- Op Income
- $-14,930,398
- FCF YoY
- -2.97%
Performance & Tape
- 52W High
- $1.25
- 52W Low
- $0.08
- 50D MA
- $0.21
- 200D MA
- $0.28
- Beta
- 1.48
- Avg Volume
- 93.08K
Get TickerSpark's AI analysis on HEMC.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HEMC.ST Coverage
We haven't published any research on HEMC.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HEMC.ST Report →